Asthme de l’enfant et de l’adolescent à l’heure de la médecine 6P : traitement personnalisé : sur quels critères ?
Authors:
- A. HamzaouiAHA. Hamzaoui
- S. LouhaichiSLS. Louhaichi
- 13 February 2023
- journal article
- research article
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 63 (3)
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patientsEuropean Respiratory Journal, 2022
- Development of a Symptom-Based Tool for Screening of Children at High Risk of Preschool AsthmaJAMA Network Open, 2022
- Paediatric asthma and non‐allergic comorbidities: A review of current risk and proposed mechanismsClinical & Experimental Allergy, 2022
- ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta‐analysisClinical & Experimental Allergy, 2021
- A System Pharmacology Multi-Omics Approach toward Uncontrolled Pediatric AsthmaJournal of Personalized Medicine, 2021
- Pediatric asthma: An unmet need for more effective, focused treatmentsPediatric Allergy and Immunology, 2018
- Individualized therapy for persistent asthma in young childrenJournal of Allergy and Clinical Immunology, 2016
- Feasibility and Impact of a School‐Based Intervention for Families of Urban Adolescents with Asthma: Results from a Randomized Pilot TrialFamily Process, 2008